Deals
Luye Medical Considers Sale of Oncology Business in Singapore, Sources Say
- A potential deal could be worth $300 million to $400 million
- Health-care firms, financial investors have expressed interest
This article is for subscribers only.
Luye Medical Group is weighing a sale of its oncology business in Singapore, people with knowledge of the matter said, potentially adding to a wave of health-care deals in the region.
The company is working with an adviser on the planned divestment of OncoCare Cancer Centre, which has seven clinics in the city-state, the people said. A deal could be worth $300 million to $400 million, the people said, asking not to be identified as the process is private.